Skip to content
Our client is the global leader in multimodality topical wound oxygen therapy. Their patented non-invasive product is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations over 12 months - because of this and more, our client is growing fast! Our client seeks enthusiastic and dedicated Wound Care Consultants who are driven to achieve outcomes, thrive within teams, aspire to leadership... more ->